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Abstract
Background: Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that causes public health problems in Asian
countries. Only a limited number of JEV-infected individuals show symptoms and develop severe encephalitis, indicating
host-dependent susceptibilities.
Methodology/Principal Findings: C3H/HeN and DBA/2 mice, which exhibit different mortalities when infected by
intraperitoneal inoculation with JEV, were used as experimental models to compare viral pathogenesis and host responses.
One hundred infectious virus particles killed 95% of C3H/HeN mice whereas only 40% of DBA/2 mice died. JEV RNA was
detected with similar low levels in peripheral lymphoid organs and in the sera of both mouse strains. High levels of viral and
cytokine RNA were observed simultaneously in the brains of C3H/HeN and DBA/2 mice starting on days 6 and 9 post-
infection, respectively. The kinetics of the cytokines in sera correlated with the viral replication in the brain. Significantly
earlier and higher titers of neutralizing antibodies were detected in the DBA/2 strain. Primary embryonic fibroblasts, bone
marrow-derived dendritic cells and macrophages from the two mouse strains were cultured. Fibroblasts displayed similar
JEV replication abilities, whereas DBA/2-derived myeloid antigen-presenting cells had lower viral infectivity and production
compared to the C3H/HeN–derived cells.
Conclusions/Significance: Mice with different susceptibilities to JEV neuroinvasion did not show changes in viral tropism
and host innate immune responses prior to viral entry into the central nervous system. However, early and high neutralizing
antibody responses may be crucial for preventing viral neuroinvasion and host fatality. In addition, low permissiveness of
myeloid dendritic cells and macrophages to JEV infection in vitro may be elements associated with late and decreased
mouse neuroinvasion.
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Introduction
Japanese encephalitis virus (JEV) is an enveloped virus with a
genome of single-stranded positive RNA approximately 11kb in
size and belongs to the genus Flavivirus in the family Flaviviridae [1].
JEV is transmitted by mosquitoes of the Culex species and has an
enzootic life cycle involving swine and birds, and could infect a
large variety of wild animals. Humans and horses are incidental
and dead end hosts of the viral cycle [2,3].
The majority of human JEV infections are asymptomatic or
mildly symptomatic, where only about 1 in 250 infected persons
develop a clinical disease. However, Japanese encephalitis is still
the leading cause of viral encephalitis in Asia with 30,000 to
50,000 cases reported yearly to the World Health Organization
and resulting in an estimated 10,000 to 15,000 deaths annually
[1,4,5]. For patients developing a more severe form of the disease,
the illness can progress to serious infection of the central nervous
system (CNS) with fatal outcomes in 30% of cases [2,4], which
indicates a distinct susceptibility to JEV infection in different
people. JEV is closely related to the West Nile virus (WNV) and St.
Louis encephalitis virus. After infection, these viruses may invade
the CNS, including the brain and spinal cord; however, the routes
employed for crossing the blood brain barrier (BBB) remain
unclear. Some reports have proposed possible mechanisms for
flaviviruses to infect peripheral cells and organs and enter into the
CNS [6,7,8,9]. Previous studies have shown that JEV can replicate
in leukocytes of humans and mice [10,11], which implies that the
virus may infect the CNS through peripheral inflammatory cells.
Initial signs of JEV infection are nonspecific and viremia is
rarely detected, rendering studies of viral and biological markers
and any correlation with disease outcomes difficult to access in
humans. Early signs of innate and cellular immune irregularities
toward JEV infection may be associated with the severity of the
disease [12,13,14]. In JEV-infected patients, an increase of
interferon (IFN)-a, interleukin (IL)-6, IL-8 in cerebrospinal fluid
(CSF) and ‘‘regulated upon activation normal T-cell expressed and
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24744
6secreted’’ (RANTES) have also been reported [14]. Low levels of
IgM and IgG were detected in both serum and CSF in patients
with fatal outcomes [15].
Mice are suitable animal models of infection with JEV, which
can reproduce symptoms and physiopathological markers ob-
served in humans [16,17,18]. A notable increase of proinflamma-
tory molecules including IFNs, macrophage migration inhibitory
factor (MIF), IL-6, RANTES and monocyte chemotactic protein-1
(MCP-1) have been reported in mice infected with JEV; however,
the strains and ages of the mice as well as the routes of viral
inoculation were diverse [18,19,20,21,22]. Laboratory mice are
generally susceptible to flaviviruses, due to the natural lack of the
flavivirus resistance gene [23,24], but different strains display
various severities of the disease. Differences in mouse susceptibil-
ities to JEV were observed after infection by peripheral routes
[25,26,27], but specific markers associated with different disease
outcomes have not yet been identified. In WNV infections,
survival rates of different mouse strains were not related to tissue
tropism and viral replication [28].
In order to identify biological and virological markers associated
with susceptibilities to JEV infection, we compared two mouse
strains exhibiting different mortality rates after JEV peripheral
infection. Data suggest that differences in viral infection of myeloid
cells leading to dissimilar ratios of JEV production and subsequent
local pro-inflammatory cytokine release with dissimilarities in level
of neutralizing antibody responses may account for variations
observed in the timing before CNS infection and mortality.
Materials and Methods
Virus
The SA14 strain of JEV (a generous gift from Pr. Yongxin Yu)
was propagated in BHK-21 cell line (purchased from Shanghai
Institute of Biological Sciences, Chinese Academy of Sciences,
Shanghai, China). Cells were infected at a multiplicity of infection
(moi) of 0.1 plaque forming unit (pfu)/cell and the virus was
harvested from the cell supernatant two days post infection (p.i.),
but before cellular cytopathic effects. Viral titers in pfu were
obtained by plaque assay using BHK-21 cell line. The virus was
aliquoted and stored at 280uC. Viral inactivation was carried out
by exposure to UV radiation (wavelength of 254 nm) at a distance
of 3 cm for 30 min on ice. Virus inactivation was tested by the
absence of immunofluorescence in BHK cells incubated for seven
days with inactivated JEV.
Mouse strains
Six-week-old female C3H/HeN and DBA/2 mice were
purchased from Vital River Lab Animal Technology Co., Ltd
(Beijing, China) and Shanghai Laboratory Animal Co., Ltd
(SLAC, Shanghai, China), respectively. The mouse experiment
protocol was approved by the Institut Pasteur of Shanghai Ethics
Committee for Animal Care (ID# 01-2006) and was carried out in
the Institut Pasteur animal facility, following the European
directive 86/609/EEC on the protection for animal used for
experimental and other scientific purposes.
Mouse infection
Mice were kept in isolators in a biosafety-level-2 animal facility
andinfected withSA14.AseriesofSA14virusdilutionsinPBSfrom
0.1 pfu to 10,000 pfu in 0.2 ml was injected by intraperitoneal (i.p.)
inoculation in C3H/HeN and DBA/2 mice. The morbidity and
mortality were observed daily for 1 month. For pathophysiological
analysis of virus infection, the mice were injected i.p. with 100 pfu.
Blood and tissue samples were harvested from three anesthetized
and sacrificed mice at days 1, 3, 5, 6, 7, 8, 9, 11, 13, 15, 17, 19, 21
p.i.. Mice showing symptoms were preferentially chosen.
Primary cell isolation and viral infection
Cells were incubated with desired viral moi for 1 hr. The virus
was subsequently removed and cells were washed three times with
PBS and incubated in culture medium. At 6, 12, 24, 48, 72, 96 hr
p.i., the supernatants and cells were collected for virus titration and
RNA extraction, respectively.
Mouse embryo fibroblasts (MEF) were prepared from 14-day-
old embryos and cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM) (Invitrogen, Carlsbad, CA, USA) that contained 10%
fetal bovine serum (FBS) and 100 U/ml penicillin and 100 mg/ml
streptomycin, at 37uCi n5 %C O 2. The cells passaged for 2 to 4
times were trypsinized, counted and then infected with the virus at
moi of 0.1 pfu/cell.
Bone marrow macrophages (BMM) and bone marrow dendritic
cells (BMDC) were generated as described previously [29,30,31].
Briefly, cells were isolated from the bone marrow of 6-week-old
mice. For generating BMM, cells were cultured in DMEM for 7
days in 10% FBS and 20% L929 conditioned medium. For
generating BMDC, cells were cultured in RPMI 1640 (GIBCO,
Grand Island, NY) for 10 days in 10% FBS, IL-4 and granulocyte-
macrophage colony-stimulating factor (GM-CSF) (PeproTech,
Inc. Rocky Hill, NJ, USA). CD11c+ BMDC were further purified
by MACS beads separation (Miltenyi Biotec, Auburn CA, USA).
Both BMM and BMDC were infected at a moi of 1 pfu/cell.
Quantitative RT-PCR
RNA was extracted using the RNeasy mini kit (QIAGEN,
Hilden, Germany) from tissue and cell samples and by the
QIAamp Viral RNA Mini Kit (QIAGEN) from sera and cell
culture supernatants according to the manufacturer’s instruction.
The primers used to detect JEV and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) RNAs and other RNA gene factors are
listed in Table 1. Isolated RNA was quantified by QuantiTect
SYBR Green RT-PCR kit (QIAGEN). Briefly, the reaction
condition was 50uC for 30 min, 95uC for 15 min, 40 cycles of
94uC for 15 sec, 55uC for 30 sec, and 72uC for 30 sec followed by
a melting curve analysis step using the ABI PRISM 7900HT Real
Time PCR System (Applied Biosystems, Foster City, CA, USA).
Histology and immunohistochemistry
Spleen, thymus and brain tissues from mice were fixed in 4%
paraformaldehyde (PFA) overnight and sectioned in paraffin. For
histological examination, the tissues were stained with haematox-
ylin and eosin. For immunohistochemistry, sections were depar-
affinized with xylene, rehydrated through successive bathes of
ethanol/water (from 100% ethanol successively to 50% ethanol till
pure water) and incubated in 3% H2O2 at room temperature. The
sections were then put in 10 mM sodium citrate buffer for 1 hr at
96uC for antigen retrieval and blocked with BSA at saturation for
20 min. Polyclonal rabbit anti-JEV envelope (E) antibody C0859
(produced in the laboratory against highly purified recombinant E
protein) was applied to the section overnight at 4uC. Horse radish
peroxidase-conjugated anti-rabbit polyclonal antibody was used as
a secondary antibody and 39-Diaminobenzidine as a chromogen
(DAKO, Glostrup, Denmark). The section was counterstained
with haematoxylin.
Immunofluorescence
After 48 hr of infection, the cells were fixed with 4% PFA and
permeabilized with permeabilization buffer (Triton X-100 0.1% in
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polyclonal antibody for 1.5 hr followed by blocking with 5% BSA
in PBS. Alexa Fluor 488 goat anti-rabbit antibody (Invitrogen,
Eugene, OR, USA) and Hoechst 33258 (Sigma, St. Louis, MO,
USA) were applied to stain the viral E protein and the cell nucleus,
respectively. The slides were mounted and the images were
visualized by fluorescence microscopy (Leica, Heidelberg, Ger-
many).
Flow Cytometry
The mock or infected BMM were trypsinized and washed with
flow cytometry staining buffer (eBiosciences, San Diego, CA, USA).
After blocking with anti-mouse CD16/32, the cells were incubated
withalexa fluor488conjugated anti-mouse F4/80 (eBiosciences) for
45 min at 4uC in the dark. The surface stained cells were fixed by
PFA, resuspended in permeabilization buffer (eBiosciences) and
then incubated with C0863 anti-JEV NS1 rabbit polyclonal
antibody (produced in the laboratory against highly purified
recombinant NS1 protein) for 1.5 hr. After washing, the alexa
fluor 633 conjugated anti-rabbit IgG secondary antibody (Invitro-
gen) was added. Fluorescence was measured using a LSRII flow
cytometer (BD biosciences, San Jose, CA, USA).
Cytokine array
The cytokine change in the sera of infected mice was tested
using a Q-Plex
TM Mouse Cytokine array (16-plex, Quansys
Biosciences, Logan, UT, USA.) according to the manufacturer’s
instructions. Briefly, the sera and antigen standards were diluted
and incubated for 1 hr at room temperature. After the substrates
were added, images were acquired using a FUJI LAS400mini
camera and analyzed with Quansys Q-View
TM Software.
Plaque reduction neutralization test
The titers of neutralizing antibodies against JEV in mouse sera
were determined by the plaque reduction neutralization test
(PRNT) as described previously [32]. Briefly, after inactivation of
the virus and complementin the sera by heating at 56uC for
30 min, two-fold serial dilutions of the samples in DMEM,
beginning with a dilution of 1:20, were incubated with 100 pfu of
JEV SA14 for 1 hr at 37uC. The mixture was incubated for 1 hr
with sub-confluent BHK cells in 24-well culture plates and
recovered with 2 ml of 1% carboxy methyl cellulose in DMEM
containing 3% FBS. After 4 days of incubation, the cell
supernatant was removed and cells were fixed and stained in a
mixture of 0.1% amidoschwarz and 25% isopropanol, 10% acetic
acid. The PRNT titers were calculated as the serum dilution that
reduced by 50% the number of pfu compared to the tests carried
out by using sera of mock-infected mice.
Statistical analysis
The statistical analysis was performed using SAS6.12 software
(SAS Institute Inc., Cary, NC, USA). Two-tailed t-tests were used
to determine the significant differences and a p value less than 0.05
was regarded to be statistically significant. Two-way analysis of
variation (ANOVA) was used to compare the two mouse strains at
different time points.
Results
Individual mouse strains show selective susceptibilities to
infection with JEV
Mice with different haplotypes have shown dissimilar suscepti-
bilities to JEV infection [25,26,27]. In the present study, 20 six-
week-old mice of H2
k (C3H/HeN) and H2
d (DBA/2) haplotype
strains were shown to be the most and the least susceptible to i.p.
doses of JEV strain SA14 ranging from 1 to 10,000 pfu,
respectively (data not shown). For the remainder of the
experiments, mice of both strains were infected with 100 pfu. In
total, 19 C3H/HeN mice (95%) died by day 17, where only eight
DBA/2 mice (40%) died by day 21 (p=0.0013) (Fig. 1A). Deaths
of C3H/HeN mice began on day 8 and 3 days later in DBA/2
(Fig. 1). Symptoms including rough fur, hunching of the back and
hind limb paralysis appeared around 2 to 3 days before total
paralysis, convulsions and death in both mouse strains (Fig. 1B, C).
Time laps between symptoms apparition and death was longer in
DBA/2 (Fig. 1B, C). After 3 weeks, all surviving mice showed no
symptoms and were sacrificed at 30 days p.i.
In contrast, intracerebral inoculation of JEV caused more rapid
and earlier deaths by day 6 p.i. in both strains and at the same rate
(data not shown), suggesting that the difference in susceptibilities of
mice towards JEV infection was likely due to virus-host
interactions before viral entry into the brain.
Virus load in tissues of JEV infected mice
RNA was extracted from sera of three mice at different time
points p.i. and the number of JEV copies was quantified by real-
time RT-PCR by comparison with a standard curve drawn from
titrated JEV RNA transcripts (data not shown). Sick mice were
Table 1. Primers of mouse genes used in the experiment for SYBR green quantitative PCR.
Gene Forward primer Reverse primer Reference
JEV 59-AGAACGGAAGAYAACCATGACTAAA-39 59-CCGCGTTTCAGCATATTGAT-39 [61]
GAPDH 59-TGACGTGCCGCCTGGAGAAA-39 59-AGTGTAGCCCAAGATGCCCTTCAG-39 [62]
CD4 59-CCCAGGTCTCGCTTCAGTTTG-3’ 59-AGGTAGGTCCCATCACCTCACAG-39 [63]
CD8b 59-GCTGGTAGTCTGCATCCTGCTTC-39 59-TTGCTAGCAGGCTATCAGTGTTGTG-39 [63]
CD11b 59-GACCGTCTGCGCGAAGGAGATA-39 59-CGCCTGCGTGTGTTGTTCTTTG-39 [64]
IFN-c 59-CGGCACAGTCATTGAAAGCCTA-39 59-GTTGCTGATGGCCTGATTGTC-39 [63]
IL-6 59-CAACGATGATGCACTTGCAGA-39 59-TGGTACTCCAGAAGACCAGAGGAA-39 [65]
IL-12p40 59-GGAAGCACGGCAGCAGAATA-39 59-AACTTGAGGGAGAAGTAGGAATGG-39 [66]
MCP-1 59-TGCAGGTCCCTGTCATGCTT-39 59-AGCAGGTGAGTGGGGCGTTA-39 [65]
RANTES 59-CTGCCGCGGGTACCATGAAG-39 59-TACAGGGTCAGAATCAAG-3’ [66]
doi:10.1371/journal.pone.0024744.t001
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than one C3H/HeN mouse picked on day 8 and another on day 9
p.i., all the mice sampled after day 11 p.i. showed symptoms of
JEV infection. Only two DBA/2 mice sacrificed at day 11 p.i. and
one at day 13 p.i. were sick.
Mild viremiawasdetected fromdays1 to 3 p.i. with a mean value
of approximately 10
3 RNA copies/ml in all mice tested, which
subsequently decreased to 10
2.1 copies/ml at day 5 p.i. (Fig. 2A).
The threshold of RNA detection of the test was 10
1.6 copies/ml.
The viral RNA loads in the sera were higher than the amount of
virus injected, which indicated that the viral load detected did not
correspond to the inoculum. Low levels of viral RNA were detected
on days 11 and 13 p.i., but only in one sick mouse (Fig. 2A).
Spleen, thymus, and brain tissues were sampled from both
infected and mock-infected mouse strains on different days p.i. and
RNA was extracted. Relative amounts of JEV RNA was compared
by real-time RT-PCR and standardized with the RNA of the
house keeping gene, GAPDH (Fig. 2B, C). The baseline of the
ratio JEV RNA/GAPDH RNA was 10
1.8 to 10
28, which
corresponded to the limit of detection of JEV RNA. Low viral
amounts were detected at days 1 to 3 p.i. in spleen tissue, which
subsequently decreased during the remaining course of the
infection (Fig. 2B), whereas JEV was undetectable in thymus
tissues from the majority of mice (Fig. 2C).
JEV RNA was detected in brain tissues of C3H/HeN mice
starting on day 6 and on day 9 p.i. in the DBA/2 strain (Fig. 2D).
Increasing amounts of viral RNA were observed before mice
showed symptoms of infection. From day 11 p.i., both mouse
strains that showed severe symptoms had similar JEV RNA loads.
At 15 days p.i. and after, none of the brains from tested from either
strain of mouse without symptoms contained viral RNA.
Histology and immunohistochemistry in infected-mouse
brain
JEV E protein or NS1 protein was detected from 6 days p.i. in
neuronal cells of the cortex and thalamus in the brain tissues of
C3H/HeN infected mice and in the hippocampus of dying mice
(Fig. S1G-I). Progressive accumulation of JEV-positive neurons and
perivascular inflammatory responses were observed in both mouse
strains. However, a delay of 2 to 3 days occurred in pathological
alterationininfected DBA/2mice comparedtoinfected C3H/HeN
mice. Figure S1 (B, C, E, F) shows perivascular and cortical
inflammatory infiltration and pathological changes after 9 days p.i.
in C3H/HeN mice, whereas milder alterations were observed on
the same day in the infected DBA/2 strain. The number of the
infected neurons was lower in DBA/2 than in C3H/HeN (Fig. S1E,
F). However, the brains of dying mice showed similar histopath-
ological changes and estimated numbers of infected neurons in both
mouse strains, which mirrored viral load data.
Figure 1. Mortality of C3H/HeN and DBA/2 mice after intraperitoneal infection with JEV. Twenty mice of each C3H/HeN and DBA/2 strain
were infected intraperitoneally with (100 pfu) of JEV strain SA14 and were observed for four weeks. The percentage of surviving C3H/HeN (open
square) and DBA/2 (black triangle) mice after infection was recorded (A). The number of sick mice was recorded daily (black column) and the
cumulative number of death is indicated (grey column). All remaining mice with no symptoms after three weeks survived (B-C).
doi:10.1371/journal.pone.0024744.g001
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molecules in brain tissue of infected mice
Histological observations showed a major infiltration of
inflammatory cells in the brain tissues of JEV-infected mice (Fig.
S1) without the possibility of identifying their phenotypes due to
the lack of immuno-reactivity of commercially available antibodies
with cellular antigens fixed in PFA-treated specimens. To
determine the phenotypes of the cells infiltrating the brain, the
mRNA concentrations of CD4, CD8b, and CD11b cells were
examined by real-time RT-PCR. The mRNA values were
standardized by using the ratio of mRNA markers to GAPDH
mRNA. A remarkable increase of CD8 mRNA was observed in
JEV-infected mice (Fig. 3B). In C3H/HeN mice, CD8 mRNA
increased significantly from day 6 p.i., while in some DBA/2 mice,
high values of CD8 mRNA were observed at day 9 p.i. The
expression of CD8 mRNA in dying mice increased approximately
100-fold compared to the negative controls of both strains
(p,0.0001) (Fig. 3B). On the contrary, slightly lower levels of
CD4 mRNA were observed in JEV-infected mice than the mock-
infected mice of both strains (p=0.041) (Fig. 3A). No significant
differences were observed in CD11b mRNA levels between the
two mouse strains and a 6-fold increase was observed in dying
mice compared with mock-infected mice (p,0.0001) (Fig. 3C). A
large variation in the values of CD8 and CD11b mRNAs was
observed amongst the three infected mice tested each day, which
may reflect the differences observed in the appearance of
symptoms and outcomes of infected mice.
The cytokine and chemokine mRNAs started to accumulate in
brain tissue from day 6 p.i and peaked after day 9 p.i. in the C3H/
HeN strain. In DBA/2 mice, the mean cytokine mRNA levels
started to increase on day 9 and peaked between days 11 and 13
p.i. (Fig. 3). A large variation in cytokine and chemokine mRNA
concentrations among the three mice tested daily was also
observed from days 6 to 9 p.i. in the C3H/HeN strain and days
9 to 13 p.i. in DBA/2 mice, which was due to the different
infection statuses of the sacrificed mice (Fig. 3D-H). In general,
similar levels of increased cytokine mRNAs were observed in dying
mice in both strains. IFN-c and IL-12p40 mRNA levels increased
more than 30-fold over the negative controls (p,0.0001) (Fig. 3D,
F), whereas the level of IL-6 reached about a 500-fold increase
(p,0.0001) (Fig. 3E). The chemokines, including MCP-1 and
RANTES, play an active role in recruiting leukocytes to
inflammatory sites and both slightly increased at day 6 p.i. in
C3H/HeN mice. The increased values of up to 100 times those of
the negative control likely followed viral neuroinvasion and
reached up to 1000 times the control values in dying mice
(p,0.0001) (Fig. 3G, H). MCP-1 and RANTES remained at low
levels in asymptomatic DBA/2 mice, whereas dying mice
displayed similar high amounts of mRNA among the two strains
(Figure 3G).
Cytokine and chemokine analyses in mouse sera
The levels of multiple cytokines and chemokines (IL-1a,I L - 1 b,
IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-17,MCP-1,IFN-c,
Figure 2. Viral loads in sera and organs of C3H/HeN and DBA/2 mice infected with JEV SA14 virus. Serum (A), spleen (B), thymus (C) and
brain tissues (D) were tested for JEV RNA by real-time RT-PCR. The viral RNA loads in the tissues were standardized with GAPDH RNA and those in the
sera were calculated as RNA copies per ml. The detection limit of RNA copies/ml is 10
1.6 for serum and of relative JEV/GAPDH (JEV/GAPDH x10
8) ratio
is 10
1.8 for the spleen and thymus tissues and 10
2 for brain tissue. The point values at the dotted line are recorded as undetectable. The white
triangles are displayed for C3H/HeN and the white squares for DBA/2 values. Symptomatic mice were recorded as dying mice and presented with
black symbols. The lines indicate the average amount of three samples studied the same day. *, p,0.05; **, p,0.01; ***, p,0.001 for comparisons
between the two mouse strains.
doi:10.1371/journal.pone.0024744.g002
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(MIP)-1a, granulocyte macrophage colony-stimulating factor (GM-
CSF) and RANTES were tested in infected mouse sera from days 1
to 11 p.i. and in three dying mice after 12 days p.i.. The cytokine
titers varied considerably between the three individuals tested daily
for each mouse strain, which could be associated with a variation
within the time frame needed for disease manifestation. Less
variation was usually observed in the titers of dying mice compared
with those surviving, presumably because mice were at the same
stage of infection and disease. IL-1a was the only cytokine that
showed a consistent decrease in its mean level from 30 pg/ml to
3 pg/ml at day 6 p.i. in the DBA/2 strain and to 9 pg/ml at day 8
p.i. in C3H/HeN mice (Fig. 4A). However, IL-1a increased to a
mean value of 40 pg/ml in very sick C3H/HeN mice, but remained
at low levels in dying DBA/2 mice. Increased titers of IL-1b,I L - 2 ,
IL-4, IL-5, IL-6, IL-12p70, IL-17, IFN-c and GM-CSF were
observed from day 6 or 7 to day 8 p.i. in C3H/HeN mice, whereas
no remarkable increase of cytokine titer appeared in sera of infected
DBA/2 mice (Fig. 4). Cytokine IL-3 showed a sharp increase at day
7 p.i. in the DBA/2 mice, whereas only a slight increase was
observed in C3H/HeN mice, but with no statistical significance
(Fig. 4D). IL-10 showed an early modest increase in DBA/2 mice
from day 3 to day 7, which then dropped to normal concentrations
at day 8 before any symptoms of disease occurred, whereas its titer
started to increase only at day 8 in sick C3H/HeN mice (Fig. 4H).
TNF-a was barely detectable in either mouse strain, but showed a
sharp increase in dying DBA/2 mice (Fig. 4M).
JEV-specific antibodies elicited in infected mice
In order to compare the host’s humoral immune responses in
the two mouse strains at early stages of infection, JEV-specific
antibodies were tested from days 1 to 11 p.i. Although sera were
heated before testing to inactivate any virus and complement
factors, the first dilution (1:20) of mock-infected mouse sera and of
sera from infected mice collected at days 1 and 3 p.i. showed non-
specific 50% decrease of the virus plaques. Sera from infected
DBA/2 mice exhibited neutralizing titers of 1:80 as early as day 5
p.i. that later reached 1:1,280 at day 8 p.i., whereas neutralizing
antibody concentrations of infected C3H/HeN mice were
significantly less at day 5 p.i. and peaked at a lower titer (1:480)
(p=0.0451) (Fig. 5).
JEV replication in primary myeloid cells and fibroblast
cultures from different strains of mice
Since macrophages and dendritic cells are potential early target
cells for flaviviral infection [12,20,33] and are antigen presenting
cells (APC) that trigger host innate and adaptive immune
Figure 3. Relative mRNA levels of antigen markers specific for inflammatory responses in the brain of infected mice. Relative levels of
mRNA from CD4, CD8 and CD11b cell markers (A, B, C) were calculated. Cytokine mRNA levels were tested for IFN-c, IL-6, IL-12p40 (D, E, F) and
chemokines MCP-1 and RANTES (G, H). All mRNAs were standardized with GAPDH and presented in log10 means 6 standard deviation for three mice
tested on the same day. mRNA expression in C3H/HeN mouse brain tissue is represented by black spots and in DBA/2 mouse brain by light grey
squares. All samples were tested three times. *, p,0.05; **, p,0.01; ***, p,0.001 for comparisons between the two mouse strains.
doi:10.1371/journal.pone.0024744.g003
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isolated from each mouse strain. The cells were infected at a moi
of 1 pfu/cell and tested for RNA viral replication (Fig. 6A, C) and
titration in cellular supernatant (Fig. 6B, D). No morphological
changes or apoptotic events occurred in infected cells up to 4 days
p.i. (data not shown). Both BMM and BMDC were permissive to
Figure 4. Cytokine and Chemokine levels in serum of JEV-infected mice. Cytokines were measured using the Q-Plex
TM Mouse Cytokine array
and were compared with the standard samples in the kit. Black spots at indicated times signifies the mean values of three C3H/HeN mice and grey
spots indicate those of DBA/2 mice. Standard deviation bars are presented for the three mice tested on the same day. MIP-1a that showed only a
negligible amount is not presented. *, p,0.05; **, p,0.01 for comparisons between the two mouse strains.
doi:10.1371/journal.pone.0024744.g004
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12 hr p.i. and reached a peak of viral production at 24 hr p.i. In
BMDC, viral replication started at 24 hr p.i. and the cells released
ten times more viruses in the cell supernatants at 48 hr p.i.
compared to BMM. When susceptibilities to JEV infection was
compared in myeloid cells from both mouse strains, the cells from
C3H/HeN mice sustained higher viral replication and produced
higher titers than those from DBA/2 mice (p,0.0001). Remark-
ably, the viruses remained at very low replication levels in DBA/2-
derived BMM, with a virus titer almost two log scales lower than
what was observed in C3H/HeN-derived cells (Fig. 6B).
In order to verify whether differences observed in APC
susceptibility to JEV infection between the two mouse strains
was reproduced in other cells, MEF were infected with JEV at a
moi of 0.1 pfu/cell. MEF were highly permissive to the virus and
similar concentrations of JEV RNA copies tested by real-time RT-
PCR were detected in infected MEF of both mouse strains
(Fig. 6E). Infectious viruses in the cell culture supernatant were
also titrated by viral plaque assay. JEV release started before 24 hr
p.i. and reached a peak of over 10
6 pfu/ml at 60 hr p.i. However,
no difference was observed between viral titers produced from
infected-cells of the two mouse strains (Fig. 6F).
JEV infectivity rates of myeloid cells derived from C3H/
HeN and DBA/2 mice
Differences of JEV replication were observed in myeloid cells
but not in MEF derived from the two mouse strains as illustrated
in the data mentioned above. In order to evaluate the ratio of
infected cells, polyclonal antibodies against the JEV E protein were
used to label infected cells and cells were subsequently observed by
immunofluorescence at 48 hr p.i. The amount of infected MEF
was similar for both mouse strains (Fig. S2). On the contrary, the
numbers of BMM- and BMDC-infected cells derived from C3H/
HeN mice were higher than those of DBA/2-derived cells (Fig.
S2). FACS analysis was carried out to more accurately estimate the
percentage of infected BMM by labeling the infected cells with an
anti-NS1 polyclonal antibody (Figure S2B, C). Consistent with the
data obtained by immunofluorescence, the ratio of BMM-infected
cells was low and the peak of infection occurred at 48 hr. The
number of JEV-infected cells derived from C3H/HeN was
11.462.2%, 24.363.6%, and 14.962.4% at 1, 2 and 3 days
p.i., respectively, whereas it was 4.760.9% (p=0.049), 8.661.5%
(p=0.029) and 2.160.6% (p=0.017) for DBA/2-derived cells
(Fig. S2). Noticeably, the F4/80 membrane antigen was presented
at higher amounts on the BMM surface within the time of
infection, which resulted from cellular activation during JEV
infection. Repeated low staining of JEV antigens in infected
BMDC using different antibodies did not provide interpretable
FACS data analysis.
Cytokine and chemokine release is replication-
dependent in JEV-infected primary cells in mice
To investigate whether innate immunity contributes to the
modulation of viral replication, IFN-b, IL-6, IL-10, IL-12p70,
MCP-1 and RANTES were examined in MEF, and in BMDC
and BMM myeloid cells (Fig. 7). UV-inactivated JEV was used as a
control of viral binding to cells but not for replication within the
cells. The inflammatory molecules tested in cells incubated with
inactivated viruses showed only slightly higher levels than those
observed in uninfected cells. No significant differences in cytokine
or chemokine values were observed in infected MEF of either
mouse strain, which reflected the similar JEV replication and
production rates observed in Fig. 6 (Fig. 7C, F, I, L, O, R). Higher
concentrations of cytokines and chemokines were observed in
JEV-infected BMM from CH3/HeN mice compared to cells
derived from the DBA/2 strain (Fig. 7A, D, G, M, P), which was
consistent with the viral replication (Fig. 6). Only IL-12p70
showed similar values (Fig. 7J). Notably, the level of IFN-b
remained very low in DBA/2 infected BMMs although it was
highly activated in C3H/HeN-derived cells (Fig. 7A). In contrast,
although IFN-b production was much higher in BMDC from
C3H/HeN mice than from DBA/2, the levels of the other
cytokines and chemokines were similar. In addition, the time of
appearance and the level of cytokine and chemokine production
showed large variations among the two APC types. Soluble
markers appeared earlier but at lower titers in BMM than in
BMDC (Fig. 7), in accordance with the JEV replication rate
(Fig. 6).
Figure 5. JEV specific antibody responses in mouse sera during the time course of infection. The plaque reduction neutralization test
(PRNT) in BHK cells was used to quantitate anti-JEV neutralizing antibodies. *, p,0.05; **, p,0.01 for comparisons between the two mouse strains.
The dotted line indicates the background from negative mouse sera.
doi:10.1371/journal.pone.0024744.g005
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Mice show similar features of acute encephalitis compared to
humans after JEV infection and have been used as a model of
flaviviral pathogenesis [17]. However, biological and virological
markers indicating the severity of Japanese encephalitis in mice
and humans remain unclear. Previous studies did not show
significant differences in JEV production in peripheral organs or in
serum among strains of mice [25,26]. Comparisons of tissue
tropism, viral replication and kinetics in C3H and B6 mice, which
differ in the number of acute WNV disease and death rates,
indicate that tissue tropism is similar for the two strains of mice
[28]. Differences in mouse susceptibilities to the flavivirus Banzi
was also observed among C3H/He and C3H/RV strains, which
Figure 6. JEV replication in primary cell cultures. BMM (A, B), BMDC (C, D) and MEF (E, F) were isolated from C3H/HeN and DBA/2 mouse strains
and infected with a moi of 1 pfu/cell for BMM and BMDC, or a mo of 0.1 pfu/cell for MEF. Total RNA was extracted at indicated times after infection.
Intracellular JEV RNA was calculated by Q-RT-PCR (A, C, E). Samples were normalized by GAPDH. Infectious virus titers in cell supernatants were
evaluated by viral plaque assay (B, D, F). Dark spots represent samples from C3H/HeN mice and white squares represent samples from DBA/2 mice.
Experiments were performed in quadruplicate for at least three independent experiments.
doi:10.1371/journal.pone.0024744.g006
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Taking advantage of different susceptibilities among mouse strains
to JEV, the objectives of this study were to identify biological
markers that could be related to differences in survival rates of
highly susceptible (C3H/HeN) and less susceptible (DBA/2) mice
infected by peripheral routes with JEV.
Replication in spleen tissue and viremia were reported in mice
infected with JEV [9,10,35]. In this study, JEV RNA was found in
low amounts in serum and spleen tissues before day 5 p.i. and no
replication was observed in thymus tissue. However, no significant
difference was observed in viral RNA in serum or spleen tissue of
either mouse strain. Not all mice had viral neuroinvasion with
lower susceptibility in DBA/2 than in C3H/HeN suggesting
differences in activated host response in the periphery, and only
mice with brain infection showed symptoms and death within the
following two days. Interestingly a difference was observed
between JEV and WNV infections and mouse recovery after
brain infection. Mice with different susceptibilities to WNV and
infected by subcutaneous route all showed brain infection but
morbidity and mortality differed between the mouse strains,
suggesting different capacities of virus clearance [33]. Pro-
inflammatory cytokines, including IFN-c, IL-6 and IL-12p40,
were produced in the brain when the JEV was replicating in
neurons of both C3H/HeN and DBA/2 mouse strains. This
finding was consistent with previous observations in mice infected
with flaviviruses [18,21,36,37]. MCP-1 and RANTES, which were
reported to play a role in recruiting immune cells to infected tissue,
increased up to 1000 fold in the brains of dying mice of both
strains. It is possible that these cytokines were produced in the
brain by residing in activated cells or were recruited by the viral
replication that further regulated the inflammatory response
[19,21]. Accumulation of cytokines and chemokines in the CNS
may accentuate progression of encephalitis instead of restricting
viral replication [21,38]. Other studies have suggested a protective
role of proinflammatory cytokines and chemokines against
flaviviral encephalitis [14,33]. A study carried out in humans
had reported a significant increase in IL-6, RANTES and IL-8 in
the CSF of patients infected with JEV compared to controls [39].
Whether the profile of cytokine production in human encephalitis
will predict the disease outcome requires further study. In all, the
viral replication and host responses in the CNS did not differ
between the resistant and susceptible mouse strains once the virus
had entered into the brain. This is consistent with similar mortality
rates observed in C3H/HeN and DBA/2 mice infected by
intracerebral routes, which suggests that the clinical differences
observed are not correlated with a distinct neurovirulence or
inflammatory response in the brain, but rather with virus-host
interactions prior to viral neuroinvasion.
Whether early events occurring during the incubation phase
could trigger innate or acquired immune responses, which
subsequently could contribute to CNS invasion of or protection
against a neurotropic flavivirus, remains poorly understood. It was
proposed that early TNF-a production during WNV mouse
infection could be a potential factor responsible for an increase in
the permeability of the BBB [40,41]. Dying DBA/2 mice had
higher levels of TNF-a, IL-3 and MCP-1 than C3H/HeN mice
although they had lower levels at the onset of the disease, which
may reflect a late activation of those cytokine pathways (Fig. 4).
However, in this study, the TNF-a level in blood remained almost
undetectable in both JEV-infected mouse strains at early stage,
suggesting that this cytokine did not contribute to the viral entry
into the brain. Moreover, none of the cytokines tested were
significantly increased in sera before the virus invaded the CNS,
suggesting that subtle changes or other factors may have a role in
vascular permeability and viral entry into the brain [42]. A higher
mortality in WNV-infected IFN-c (-/-) and TCR-D (-/-) mice
suggested that IFN-c plays a protective role in the early stages of
infection before viral dissemination to the CNS [43,44]. However,
an increased level of IFN-c was observed in JEV-infected C3H/
HeN mouse sera, which increased slightly at day 7 p.i. and
reached maximum values when mice were symptomatic, indicat-
ing a minor role in the modulation of JEV entry into the CNS.
The amount of cytokines including IL-6, IL-4, IL-12p70 and
RANTES, started to increase in C3H/HeN mouse sera only after
day 6 p.i., when the virus was already detected in brain tissue. It
was observed that in C3H/HeN mice, the level of proinflamma-
tory cytokines IL-6 and RANTES correlated with viral replication
levels and the severity of disease and was detected in the CSF and
sera of flaviviral-infected patients [14,39,45]. No significant
difference was found in the amount of cytokine transcriptome
levels in spleen or thymus tissues among mock-infected, moder-
ately sick or severely ill mice at any time (data not shown),
indicating very low to no viral detection in these organs. However,
a recent study has found an mRNA up-regulation of proin-
flammatory cytokines and chemokines, including IL-1, IL-6, IFN-
c, MCP-1, and IFN-inducible transcription factors, in both spleen
and brain tissues from JEV-infected BALB/c mice [46]. Mice used
in that study were only one week old, and their immunological
immaturity to contain virus replication may explain differences
observed in response of lymphoid tissues to infection with JEV.
Correlation between the presence of neutralizing antibodies and
protection against viral diseases is generally well accepted in
flavivirology. Passive protection of mice infected with JEV [47] or
WNV [33,48,49] clearly indicates a crucial role in humoral
immunity to viral diffusion and fatal outcomes. In C3H/HeN,
JEV was detected in the brain tissue of infected mice at day 6 p.i.,
which appeared at the same time as neutralizing antibodies.
Conversely, no significant viral load was detected in DBA/2
infected brain tissues before day 9 p.i. where neutralizing
antibodies were detected at day 5 p.i. and at higher levels than
in the C3H/HeN strain. These differences may have contributed
to the delay and partial prevention of JEV neuroinvasion in DBA/
2 mice.
MEF have been extensively used to study the host immune
response towards virus infection [44] and the genetic susceptibility
(Flv
S) to flaviviral infection referred to as the IFN type I pathway
knockdown mutation, which leads to higher replication levels in
MEF [23,24,43]. Therefore, MEF derived from both mouse
strains were infected with JEV to compare viral replication and
innate immune responses. JEV replicated at the same rate in both
mouse-derived MEF, which was accompanied with similar
cytokine and chemokine production [43,50]. This suggested that
there was no apparent modification in MEF tropism and host-cell
innate immune responses to JEV infection between strains.
Figure 7. Cytokines produced by BMM and MEF infected with JEV. The profiles of cytokine production including IFN-b, IL-6, IL-10, IL-12p70,
MCP-1 and RANTES were quantified at indicated times post-infection in supernatants of JEV-infected BMM (A, D, G, J, M, P), BMDC (B, E, H, K, N) and
MEF (C, F, I, L, O, R). The means 6 standard deviation was calculated from the values of three mice. For negative controls, cytokine production was
tested from cell supernatants 48 hr with no virus or after incubation with UV-inactivated virus (inactivated). Black columns represent values of
samples derived from C3H/HeN-derived cells and grey columns represent those from DBA/2-derived cells.
doi:10.1371/journal.pone.0024744.g007
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[10,20,51,52,53]. In addition, dendritic cells are potential early
target cells of flaviviral infection after the bite of an infected
mosquito [54,55,56]. Macrophagic cells were reported to have a
protective role in flaviviral infection, including direct clearance
through viral uptake from circulation without viral progeny
production or apoptosis of infected cells [8,57,58]. However, some
studies have reported that macrophages act as reservoirs that carry
viruses from the periphery to the CNS [11,53]. In this study,
quantitation of intracellular viral RNA and of viral particles
released from infected cells showed that C3H/HeN-derived
myeloid cells were significantly more susceptible to JEV-infection
than those derived from the DBA/2 strain. The viruses replicated
efficiently in myeloid cells of C3H/HeN strains, while almost no or
much lower replication was detected in BMM and BMDC of
DBA/2 mice. The immunofluorescence and FACS analyses
showed differences in the number of infected CH3H/HeN-
derived myeloid cells compared to DBA/2-derived cells. Differ-
ences in cell infectivity by flaviviruses may be due to (co)receptor
polymorphisms. Mannose receptors and DC-SIGN or DC-
SIGNR receptors on macrophages are utilized by DENV and
WNV, respectively [59,60]. However, macrophage cell receptors
for JEV remain unknown, and FACS analysis of DC-SIGN, DC-
SIGNR or mannose receptor of BMDC and BMM of the two
mouse strains did not show significant difference in the level of
those receptors (data not shown). After 1 h of incubation with JEV,
quantitation of viral RNA binding or internalization in cells
indicated similar viral uptakes by BMM from both mouse strains
(data not shown). It is possible that macrophagic cells from DBA/2
mice may modulate cell infection through partial viral degradation
in the phagosomic pathway, an anti-viral process that has been
described in DENV infection [8,58].
Surprisingly, almost no IFN-b was induced in myeloid cells
from DBA/2 mice, although it was produced at high levels in
MEF. Whether this cytokine knockdown in myeloid cells plays a
role in the reduced amount of virus and DBA/2 mouse
susceptibility to JEV compared to the C3H/HeN strain requires
further study. The IL-6, IL-10, MCP-1 and RANTES production
paralleled viral replication in BMM from both mouse strains.
Although viral replication was lower in BMDC from DBA/2
compared with C3H/HeN mice, the levels of these cytokines
increased to similar levels, which suggested that differences
observed in the viral replication during JEV infection may be
correlated more to susceptibility of APCs from C3H/HeN mice to
JEV infection than to activation of these cytokines. Whether
higher APC susceptibility was directly or indirectly responsible for
the more efficient neuroinvasion in C3H/HeN mice is difficult to
address at this time without a clear understanding of the pathway
used by JEV to cross the BBB.
In conclusion, the comparative in vivo mouse infection did not
show clear-cut differences in viral or soluble markers of innate
immunity among highly susceptible and less susceptible mouse
strains. However, earlier and greater amounts of neutralizing
antibodies could have limited the invasion of JEV in the brain in
less susceptible mice. Moreover, a lower JEV infectivity capacity
was observed in bone marrow-derived primary macrophages and
dendritic cells of the less susceptible mouse strain. These
differences represent biological factors which may contribute to
partial protection against neuroinvasion in DBA/2.
Supporting Information
Figure S1 Histopathological observation of brains from
JEV- infected mice. Photomicrographs of staining was taken in
mock mice (A, D), sick mice of the C3H/HeN strain (B, E) and
one of the DBA/2 strain at day 9 post-infection (C, F). Compared
with the negative control, the brain tissues of both sick mice
displayed inflammatory cell infiltration, but the infiltration of
DBA/2 was milder. Hematoxylin and eosin staining was
preformed for brain tissue (A, B, C, X100). Rabbit anti-JEV
NS1 polyclonal antibodies were used for detection of the virus in
the brain. The positive staining of neurons in C3H/HeN mice was
more severe than in the DBA/2 strain (D, E, F, x200).
Representative photos were shown in different brain regions
including the cerebral cortex (G), thalamus (H) and hippocampus
(I) for one sample of C3H/HeN mice at day 15 post-infection,
x200 magnification.
(TIF)
Figure S2 Infection ratio of MEF, BMM and BMDC.
C3H/HeN- or DBA/2-derived MEF and myeloid cells (BMM
and BMDC) were infected with JEV at a moi of 0.1 pfu/cell and 1
pfu/cell, respectively, and fixed 48 hr p.i. The number of cells
expressing JEV E-protein was checked by immunofluorescence
using anti-E polyclonal antibodies (A). Photomicrographs (magni-
fication x40) are representative for three wells per group and
repeated for four independent experiments. FACS analysis was
performed on JEV-infected BMM at 0, 24, 48 and 72 hr p.i. using
JEV anti-NS1 polyclonal antibody (B). The mean F4/80+NS1+
percentage is presented graphically (C). *, p,0.05 for comparisons
between the two mouse strain.
(TIF)
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